While prior studies have linked Gpx4 deletion in neurons and adipocytes to worsened metabolic outcomes [20, 21], our findings reveal that loss of GPX4 in macrophages produces the opposite effect—attenuating obesity, dyslipidemia, and insulin resistance. This evidence concerns the gene GPX4 and metabolic syndrome.